Sfoglia per AUTORE
LEVIS A
Collezione AO Cuneo

  

Items : 4

Effects of erythropoiesis-stimulating agents on overall survival of International Prognostic Scoring System Low/Intermediate-1 risk, transfusion-independent myelodysplastic syndrome patients: a cohort study. in Haematologica / Haematologica. 2019 Jan;104(1):e4-e8. doi: 10.3324/haematol.2017.183590. Epub 2018 Aug 3.

2019
AO Cuneo
AO Ordine Mauriziano
AOU Città della Salute di Torino

Santini V; Levis A; Musto P; Tassara R; Finelli C; Saglio G; Bonferroni M; Allione B; Balleari E; Poloni A; Cametti G; Ferrero D; Sanna A; Ceccarelli M; Salvi F; Danise P; Masiera E; Castiglione A; Gioia D; Messa E; Messa E; Gioia D; Masiera E; Castiglione A; Ceccarelli M; Salvi F; Danise P; Sanna A; Allione B; et alii...

Erythroid response during iron chelation therapy in a cohort of patients affected by hematologic malignancies and aplastic anemia with transfusion requirement and iron overload: a FISM Italian multicenter retrospective study. in Leukemia & lymphoma / Leuk Lymphoma. 2017 Nov;58(11):2752-2754. doi: 10.1080/10428194.2017.1312385. Epub 2017 May 9.

2017
AO Cuneo
ASL Torino 5
AOU Città della Salute di Torino

Cilloni D; Saglio G; Levis A; Nicoli P; Gioia D; De Gobbi M; Calabrese C; Allione B; Ferrero D; Salvi F; Lunghi M; Bonferroni M; Castiglione A; Messa E; Biale L; Messa E; Biale L; Castiglione A; Lunghi M; Bonferroni M; Salvi F; Allione B; Ferrero D; Calabrese C; De Gobbi M; Nicoli P; Gioia D; Levis A; Saglio G; et alii...

Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial. in Blood / Blood. 2007 Oct 1;110(7):2316-23. doi: 10.1182/blood-2007-02-074641. Epub 2007 Jun 20.

2007
AO Cuneo

Secondo V; Rigacci L; Pinto A; Manna A; Levis A; Tucci A; Specchia MR; Billio A; Patti C; Zaja F; Gallamini A; Iannitto E; Zoli V; Torchio P; Pileri S; Tarella C;

The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease. in Haematologica / Haematologica. 2006 Apr;91(4):475-81.

2006
AO Cuneo

Gallamini A; Rigacci L; Merli F; Nassi L; Bosi A; Capodanno I; Luminari S; Vitolo U; Sancetta R; Iannitto E; Trentin L; Stelitano C; Tavera S; Biggi A; Castagnoli A; Versari A; Gregianin M; Pelosi E; Torchio P; Levis A;